Pds biotech to be added to russell 2000® and russell 3000® indexes effective june 26, 2023

Florham park, n.j., june 20, 2023 (globe newswire) -- pds biotechnology corp. (nasdaq: pdsb), a clinical-stage company developing a growing pipeline of targeted immunotherapies for cancer and infectious disease, announced today its expected addition to the broad-market russell 2000® and the russell 3000® indexes in accordance with the 2023 russell indexes annual reconstitution. pds biotech's anticipated inclusion in the russell indexes will be effective after the u.s. market opens on monday, june 26, 2023.
PDSB Ratings Summary
PDSB Quant Ranking